Portage Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	Current	2022	2021	2020	2019	2018
Market Capitalization	6	53	88	338	-	-
Market Cap Growth	-	-39.84%	-74.06%	-	-	-
Enterprise Value	8	53	64	335	0	-3
PE Ratio	-0.22	-0.50	-4.57	-19.66	-	-
PB Ratio	0.18	0.69	0.72	3.33	-	-
P/FCF Ratio	-2.04	-4.37	-12.96	-78.89	-	-
P/OCF Ratio	-2.04	-4.37	-12.96	-78.89	-	-
EV/EBITDA Ratio	-0.20	-0.43	-4.35	-22.79	-0.07	0.74
EV/EBIT Ratio	-0.20	-0.43	-4.35	-22.79	-0.07	0.74
EV/FCF Ratio	-2.19	-4.39	-9.51	-78.28	-0.12	3.04
Debt / Equity Ratio	0.24	0.15	-	0.00	0.04	0.04
Debt / EBITDA Ratio	-0.04	-0.09	-	-0.01	-0.62	-1.04
Debt / FCF Ratio	-0.48	-0.94	-	-0.04	-0.99	-4.27
Quick Ratio	1.97	5.89	29.82	0.86	1.25	3.49
Current Ratio	2.78	7.33	31.71	1.54	1.48	3.65
Interest Coverage	-8967.89	-13612.56	-343.58	-83.14	-10.69	-39.84
Return on Equity (ROE)	-232.80%	-76.90%	-15.30%	-16.70%	-7.40%	-
Return on Assets (ROA)	-171.00%	-58.20%	-9.70%	-9.70%	-4.20%	-
Return on Capital (ROIC)	-160.58%	-69.19%	-12.86%	-12.24%	-5.97%	-2.67%
Earnings Yield	-2525.68%	-198.43%	-21.86%	-5.09%	-	-
FCF Yield	-276.38%	-22.89%	-7.71%	-1.27%	-	-
Buyback Yield / Dilution	-22.64%	-23.42%	-11.31%	-7.13%	-127.22%	-78.76%
Total Shareholder Return	-22.64%	-23.42%	-11.31%	-7.13%	-127.22%	-78.76%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).